🔎 Trials Near Me

Beranda › Kanker (semua jenis) › Nebraska › Omaha

Uji klinis Kanker (semua jenis) di Omaha, NE

18 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Omaha (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Menerima pesertaFase 2/3
  • Nebraska Medicine, Omaha
  • Nebraska Medicine - Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Menerima pesertaFase 3
  • University of Nebraska Medical Center, Omaha
  • Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06901531

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Menerima pesertaFase 2
  • University of Nebraska Medical Center, Omaha
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Menerima pesertaFase 2/3
  • University Of Nebraska Medical Center, Omaha
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03435796

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Menerima pesertaFase 2
  • University of Nebraska Medical Center, Omaha
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Menerima pesertaFase 3
  • Nebraska Cancer Specialists, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06072612

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

Menerima pesertaFase 1
  • Nebraska Cancer Specialists, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07660055

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Children's Hospital and Medical Center of Omaha, Omaha
  • University of Nebraska Medical Center, Omaha
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Menerima pesertaFase 3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Nebraska Medicine-Village Pointe, Omaha
  • dan 8 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Menerima pesertaFase 1/2
  • Nebraska Cancer Specialists, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT04198766

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Menerima pesertaFase 1
  • Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05650632

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Menerima peserta
  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Menerima pesertaFase 1/2
  • Fred and Pamela Buffett Cancer Center, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

GEMINI-NSCLC: NSCLC Biomarker Study

Menerima pesertaStudi observasional
  • Nebraska Cancer Specialists, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Omaha
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • University of Nebraska Medical Center, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2025 · NCT05970497

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Menerima pesertaStudi observasional
  • Nebraska Cancer Specialists, Omaha
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2025 · NCT05234177

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Menerima peserta
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medicine, Omaha
  • Nebraska Medicine - Bellevue, Bellevue · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883

Uji klinis Kanker (semua jenis) di kota lain

Studi lain di Omaha

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.